Compare HSCS & TWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HSCS | TWAV |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 7.2M |
| IPO Year | 2022 | N/A |
| Metric | HSCS | TWAV |
|---|---|---|
| Price | $3.15 | $1.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.20 | N/A |
| AVG Volume (30 Days) | ★ 69.1K | 56.5K |
| Earning Date | 12-15-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $8,669.00 | ★ $2,378,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.01 | $1.69 |
| 52 Week High | $6.47 | $5.50 |
| Indicator | HSCS | TWAV |
|---|---|---|
| Relative Strength Index (RSI) | 64.45 | N/A |
| Support Level | $2.16 | N/A |
| Resistance Level | $2.83 | N/A |
| Average True Range (ATR) | 0.25 | 0.00 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 94.44 | 0.00 |
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.